Skip to main content
. 2021 Jul 28;2021(7):CD015017. doi: 10.1002/14651858.CD015017.pub2

1.10. Analysis.

1.10

Comparison 1: Ivermectin compared to placebo or standard of care for people with moderate‐to‐severe COVID‐19 treated in the inpatient setting, Outcome 10: Duration of hospitalization (primary analysis)